Search Results - "Bodrogi, István"

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma by Hudes, Gary, Carducci, Michael, Tomczak, Piotr, Dutcher, Janice, Figlin, Robert, Kapoor, Anil, Staroslawska, Elzbieta, Sosman, Jeffrey, McDermott, David, Bodrogi, István, Kovacevic, Zoran, Lesovoy, Vladimir, Schmidt-Wolf, Ingo G.H, Barbarash, Olga, Gokmen, Erhan, O'Toole, Timothy, Lustgarten, Stephanie, Moore, Laurence, Motzer, Robert J

“…This large, multicenter trial compared temsirolimus with interferon alfa alone and with a combination of the two drugs in patients with newly diagnosed…”
Get full text

Randomized, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer by HEYMACH, John V, JOHNSON, Bruce E, KENNEDY, Sarah J, HOU, Jeannie, HERBST, Roy S, PRAGER, Diane, CSADA, Edit, ROUBEC, Jaromir, PESEK, Milos, SPASOVA, Irena, BELANI, Chandra P, BODROGI, Istvdn, GADGEEL, Shirish

“…Vandetanib is a once-daily oral inhibitor of vascular endothelial growth factor receptor-2 and epidermal growth factor receptor kinase activity. The activity…”
Get full text

Neutrophil-to-lymphocyte ratio in primary mediastinal germ cell tumors: A retrospective analysis of >20 years single institution experience by Géczi, Lajos, Budai, Barna, Polk, Nándor, Fazekas, Fruzsina, Bodrogi, István, Biró, Krisztina

“…Objectives: To obtain information on outcome stratified by histology, extent and primary treatment patients’ data with primary malignant mediastinal germ cell…”
Get full text

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy by Grünwald, Viktor, Karakiewicz, Pierre I, Bavbek, Sevil E, Miller, Kurt, Machiels, Jean-Pascal, Lee, Se-Hoon, Larkin, James, Bono, Petri, Rha, Sun Young, Castellano, Daniel, Blank, Christian U, Knox, Jennifer J, Hawkins, Robert, Anak, Oezlem, Rosamilia, Marianne, Booth, Jocelyn, Pirotta, Nicoletta, Bodrogi, István

“…Abstract Background and objectives The RECORD-1 trial established the clinical benefit of everolimus in patients with metastatic renal cell carcinoma (mRCC)…”
Get full text

Outcome of Restarted Sunitinib Treatment in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Trial and Combined Case Reports from Literature by Nagyiványi, Krisztián, Budai, Barna, Küronya, Zsófia, Gyergyay, Fruzsina, Bíró, Krisztina, Bodrogi, István, Géczi, Lajos

“…In practice it is still not clear whether a drug holiday in sunitinib (Su) treatment can be safety, without impairing the overall outcome of patients with…”
Get full text

Topoisomerase-IIα expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel by Durbecq, Virginie, Paesmans, Marianne, Cardoso, Fatima, Desmedt, Christine, Di Leo, Angelo, Chan, Stephen, Friedrichs, Kay, Pinter, Tamas, Van Belle, Simon, Murray, Elizabeth, Bodrogi, István, Walpole, Euan, Lesperance, Bernard, Korec, Stefan, Crown, John, Simmonds, Peter, Perren, Thimothy J, Leroy, Jean-Yves, Rouas, Ghizlane, Sotiriou, Christos, Piccart, Martine, Larsimont, Denis

“…Purpose: The predictive value of topoisomerase-IIα (topo-II) has been evaluated in advanced breast cancer patients randomly treated with single-agent…”
Get full text

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial by de Bono, Johann Sebastian, Dr, Oudard, Stephane, MD, Ozguroglu, Mustafa, MD, Hansen, Steinbjørn, MD, Machiels, Jean-Pascal, MD, Kocak, Ivo, MD, Gravis, Gwenaëlle, MD, Bodrogi, Istvan, MD, Mackenzie, Mary J, MD, Shen, Liji, PhD, Roessner, Martin, MS, Gupta, Sunil, MD, Sartor, A Oliver, MD

“…Summary Background Cabazitaxel is a novel tubulin-binding taxane drug with antitumour activity in docetaxel-resistant cancers. We aimed to compare the efficacy…”
Get full text

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial by Escudier, Bernard, Dr, Prof, Pluzanska, Anna, Prof, Koralewski, Piotr, MD, Ravaud, Alain, Prof, Bracarda, Sergio, Prof, Szczylik, Cezary, Prof, Chevreau, Christine, MD, Filipek, Marek, MD, Melichar, Bohuslav, MD, Bajetta, Emilio, Prof, Gorbunova, Vera, Prof, Bay, Jacques-Olivier, MD, Bodrogi, Istvan, MD, Jagiello-Gruszfeld, Agnieszka, MD, Moore, Nicola, MSc

“…Summary Background Vascular endothelial growth factor (VEGF) inhibition is a valid therapeutic approach in renal cell carcinoma. Therefore, an investigation of…”
Get full text

Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial by STERNBERG, Cora N, PETRYLAK, Daniel P, BODROGI, Istvan, HARPER, Peter, WIRTH, Manfred, BERRY, William, PETRONE, Michael E, MCKEARN, Thomas J, NOURSALEHI, Mojtaba, GEORGE, Martine, ROZENCWEIG, Marcel, SARTOR, Oliver, WITJES, J. Alfred, DEMKOW, Tomasz, FERRERO, Jean-Marc, EYMARD, Jean-Christophe, FALCON, Silvia, CALABRO, Fabio, JAMES, Nicholas

“…This multinational, double-blind, randomized, placebo-controlled, phase III trial assessed the efficacy and tolerability of the oral platinum analog…”
Get full text

The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary by GECZI, Lajos, GOMEZ, Frederic, BAK, Mihaly, BODROGI, Istvan

“…To examine the incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral testicular cancer in the…”
Get full text

Clinical Relevance of HER-2/neu Expression in Germ-cell Testicular Tumors by MANDOKY, Laszlo, GECZI, Lajos, BODROGI, Istvan, TOTH, Jozsef, CSUKA, Orsolya, KASLER, Miklos, BAK, Mihaly

“…Background: Amplification and/or overexpression of HER-2/neu are associated with poor clinical outcome in several epithelial tumors. However, the exact…”
Get full text

Increased predisposition to cancer in brothers and offspring of testicular tumor patients by Gundy, Sarolta, Babosa, Mária, Baki, Márta, Bodrogi, István

“…Cancer susceptibility was examined in first-degree relatives of 293 testicular tumor patients (TTPs) and 586 age-matched healthy males. Significantly increased…”
Get full text

Expression and Prognostic Value of the Lung Resistance-related Protein (LRP) in Germ Cell Testicular Tumors by MANDOKY, Laszlo, GECZI, Lajos, DOLESCHALL, Zoltan, BODROGI, Istvan, CSUKA, Orsolya, KASLER, Miklos, BAK, Mihaly

“…Background: Lung resistance-related protein (LRP) was first detected in a non-P-glycoprotein-mediated multidrug-resistant lung cancer cell line and has been…”
Get full text

Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer by CHAN, S, FRIEDRICHS, K, YELLE, L, VON MINCKWITZ, G, KOREC, S, SIMMONDS, P, BUZZI, F, MANCHA, R. G, RICHARDSON, G, WALPOLE, E, RONZONI, M, MURAWSKY, M, NOEL, D, ALAKL, M, RIVA, A, CROWN, J, PINTER, T, VAN BELLE, S, VOROBIOF, D, DUARTE, R, GIL, M. G, BODROGI, I, MURRAY, E

“…This phase III study compared docetaxel and doxorubicin in patients with metastatic breast cancer who had received previous alkylating agent-containing…”
Get full text

Three-year results of the first educational and early detection program for testicular cancer in Hungary by Géczi, L, Gomez, F, Horváth, Z, Bak, M, Kisbenedek, L, Bodrogi, I

“…To determine whether a testicular self-examination-based early-detection program may help in the early diagnosis of testicular cancer. Advertisements were…”
Get more information

A randomized, double-blind, placebo-controlled phase II study of vandetanib plus docetaxel/prednisolone in patients with hormone-refractory prostate cancer by Horti, József, Widmark, Anders, Stenzl, Arnulf, Federico, Miriam H, Abratt, Raymond P, Sanders, Nick, Pover, Gillian M, Bodrogi, István

“…Vandetanib (ZACTIMA) is a once-daily oral anticancer drug that selectively inhibits vascular endothelial growth factor receptor, epidermal growth factor…”
Get more information

Influence of hMLH1 Methylation, Mismatch Repair Deficiency and Microsatellite Instability on Chemoresistance of Testicular Germ-cell Tumors by OLASZ, Judit, MANDOKY, Laszlo, GECZI, Lajos, BODROGI, Istvan, CSUKA, Orsolya, BAK, Mihaly

“…Background: Cisplatin-based chemotherapy can cure more than 80% of metastatic germ-cell testicular tumors (GCTs). The response to cisplatin-based chemotherapy…”
Get full text

The International Testicular Cancer Linkage Consortium: A clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred by Mai, Phuong L., M.D., M.S, Friedlander, Michael, M.D, Tucker, Kathy, M.B.B.S, Phillips, Kelly-Anne, M.D., M.B.B.S, Hogg, David, M.D, Jewett, Michael A.S., M.D, Lohynska, Radka, M.D, Daugaard, Gedske, M.D., D.M.Sc, Richard, Stéphane, M.D., Ph.D, Bonaïti-Pellié, Catherine, M.D., Ph.D, Heidenreich, Axel, M.D, Albers, Peter, M.D, Bodrogi, Istvan, M.D, Geczi, Lajos, M.D, Olah, Edith, Ph.D., D.Sc, Daly, Peter A., M.D, Guilford, Parry, Ph.D, Fosså, Sophie D., M.D., Ph.D, Heimdal, Ketil, M.D., Ph.D, Liubchenko, Ludmila, M.D, Tjulandin, Sergei A., M.D, Stoll, Hans, R.N., M.Sc, Weber, Walter, M.D, Easton, Douglas F., Ph.D, Dudakia, Darshna, Huddart, Robert, M.D, Stratton, Michael R., M.D., Ph.D, Einhorn, Lawrence, M.D, Korde, Larissa, M.D., Ph.D, Nathanson, Katherine L., M.D, Bishop, D. Timothy, Ph.D, Rapley, Elizabeth A., Ph.D, Greene, Mark H., M.D

“…Abstract Objectives Familial aggregation of testicular germ cell tumor (TGCT) has been reported, but it is unclear if familial TGCT represents a unique entity…”
Get full text

Apoptosis Regulation and Spontaneous Apoptosis Index of Testicular Germ Cell Tumors are Associated with Differentiation and Resistance to Systemic Treatment by MANDOKY, Laszlo, SZENDE, Béla, GECZI, Lajos, BODROGI, Istvan, KASLER, Miklos, BAK, Mihaly

“…Background: Cisplatin-based chemotherapy can cure more than 80% of metastatic germ cell testicular tumors (GCT). Germ cells are particularly susceptible to…”
Get full text

Effect of angiogenesis inhibitors on renal cell carcinoma by Bodrogi, István

“…Sporadic renal cell carcinomas are characterized by EGFR (HER-1) and EGFR-2 (HER-2) expression, however, signal transduction inhibitors of this pathway were…”
Get more information